Shanghai New Hualian Pharmaceutical Co., Ltd. is a national high-tech enterprise. Its predecessor is Xinhualian pharmaceutical factory of Shanghai Pharmaceutical (Group) Co., Ltd., which has a pharmaceutical history of 80 years since its establishment in 1939. The company is located in No. 217, Minle Road, Xinghuo Development Zone, Fengxian District, Shanghai, covering an area of 341 Mu and a building area of 67000 square meters. At present, it has 40 drug approvals and 18 GMP workshops. Among them, mifepristone and other products have passed the US FDA, isotretinoin and other products have obtained the CEP certificate issued by European EDQM, and many products have passed the certification and registration in many countries and regions.

        The company has professional R & D and industrialization capabilities of pharmaceutical products, standardized GMP management system, advanced pharmaceutical testing instruments and production equipment, and a stable professional team. The company has established a strategic partnership of mutual benefit and win-win cooperation with a number of famous pharmaceutical enterprises, R & D institutions and scientific research institutions. Has been committed to the research and development of high-tech pharmaceutical products and pharmaceutical industrialization.

        The company has established the business philosophy of "high quality, high efficiency and high reputation", pursues the harmony of enterprise benefit, employee benefit and social value, wholeheartedly provides high-quality drugs for the society, achieves excellence with sincerity and benefits mankind with science and technology.